Ginkmedis - Company finances
|
EUR
|
2023
From: 2023-08-17
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 5,931 | 17,996 | 24,758 |
| Profit before tax | 2,027 | 945 | 110 |
| Net profit | 2,027 | 896 | 84 |
| Equity | 2,069 | 2,965 | 3,049 |
| Liabilities | 520 | 213 | 1,041 |
| Non-current assets | 2,333 | 2,994 | 3,822 |
| Current assets | 256 | 79 | 268 |
| Total assets | 2,589 | 3,073 | 4,090 |
|
Taxes paid
|
|||
| STI taxes | - | 3 | 66 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +203.4% | +37.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 78.3% | 29.2% | 2.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 98.0% | 30.2% | 2.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 34.2% | 5.0% | 0.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 34.2% | 5.3% | 0.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.1 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Ginkmedis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-07 | 80.48 |
| 2026-09-01 | 2026-09-02 | 80.48 |
| 2026-07-01 | 2026-07-31 | 80.48 |
| 2026-05-03 | 2026-05-31 | 80.48 |
| 2025-03-21 | 2025-03-31 | 98.03 |
| 2025-03-04 | 2025-03-20 | 144.90 |
| 2025-03-03 | 2025-03-03 | 72.45 |
| 2025-03-01 | 2025-03-02 | 144.90 |
| 2025-02-01 | 2025-02-28 | 72.45 |
| 2024-12-03 | 2024-12-31 | 193.50 |
| 2024-11-04 | 2024-12-02 | 129.00 |
| 2024-10-01 | 2024-11-03 | 64.50 |
| 2024-09-03 | 2024-09-30 | 516.00 |
| 2024-08-01 | 2024-09-02 | 451.50 |
| 2024-07-02 | 2024-07-31 | 387.00 |
| 2024-06-03 | 2024-07-01 | 322.50 |
| 2024-05-02 | 2024-06-02 | 258.00 |
| 2024-04-03 | 2024-05-01 | 193.50 |
| 2024-03-01 | 2024-04-02 | 129.00 |
| 2024-02-01 | 2024-02-29 | 64.50 |
| 2023-12-01 | 2023-12-31 | 117.26 |
| 2023-11-03 | 2023-11-30 | 58.63 |
Ginkmedis - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-04-09 | 2026-04-14 | 14.0 |
| 2025-03-26 | 2025-03-27 | 17.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Ginkmedis, MB (code 306381116) is a Small partnership engaged in the manufacture of wooden prefabricated buildings and structures. In the latest financial year, 2025, the company generated revenue of €24.8K and net profit of €84, which resulted in a profit margin of 0.3%. Profitability was much lower than in 2024, when revenue was €18.0K and net profit €896, and also below 2023, when revenue was €5.9K and net profit €2.0K for a 136-day period. Over the full 2023–2025 period, revenue expanded steadily, while profit declined significantly as operating scale increased. The 2025 balance sheet shows total assets of €4.1K, equity of €3.0K and liabilities of €1.0K. Equity represented 74.5% of assets, and debt-to-equity stood at 0.34. Asset turnover was 6.05x, indicating that the company generated relatively high revenue compared with its asset base. Return on equity was 2.8% and return on assets 2.0% in 2025.